MITUY yields 4.24% · JNJ yields 2.14%● Live data
📍 MITUY pulled ahead of the other in Year 1
Combined, MITUY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MITUY + JNJ for your $10,000?
Mitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.
Full MITUY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.